Condition
    Effectiveness 1/5

    Bitter Melon for Type 2 Diabetes

    Bitter melon lowers glucose convincingly in laboratory models and unconvincingly in people. The most informative trial found it significantly less effective than metformin, and systematic review concluded the evidence base cannot support a recommendation.

    Overview

    Bitter melon lowers glucose convincingly in laboratory models and unconvincingly in people. The most informative trial found it significantly less effective than metformin, and systematic review concluded the evidence base cannot support a recommendation.

    Verdict

    Insufficient evidence

    Not recommended as a glucose-lowering therapy. Cochrane found evidence insufficient and it underperformed metformin head to head.

    How It Works

    Polypeptide-p has insulin-like structure and activity in animals, while charantin and cucurbitane triterpenoids activate AMPK and promote GLUT4 translocation. Poor oral bioavailability of the peptide fraction is the most likely explanation for the gap between preclinical promise and clinical results.

    Dosing & Protocol

    Typical dose

    Recommended dose
    1,000-2,000 mg/day standardised extract before meals
    Expected timeframe
    12 weeks; if HbA1c is unchanged, stop

    Protocol

    timing
    Before meals
    starting dose
    500 mg twice daily before meals
    typical range
    1,000-2,000 mg/day
    assessment point
    HbA1c at 12 weeks; discontinue if unchanged

    Evidence

    What the studies say

    A Cochrane systematic review of randomised trials in type 2 diabetes concluded there was insufficient evidence to recommend bitter melon, citing small studies and methodological limitations. A four-arm randomised trial comparing bitter melon at 500, 1,000 and 2,000 mg/day against metformin found a significant fructosamine reduction only at the highest dose, and one substantially smaller than metformin produced. Later trials have been mixed, with some showing small fasting glucose reductions and others none. No trial has demonstrated an HbA1c benefit of clinical consequence.

    Momordica charantia for type 2 diabetes mellitus: hypoglycemic efficacy and safety in patients with type 2 diabetes mellitus

    Score: 7/10
    2020
    rct
    n=90

    Kim SK, Jung J, Jung JH +2 more

    After treatment with bitter melon extract for 12 weeks, the HbA1c levels of the bitter melon and placebo groups remained unchanged; however, the average fasting glucose level of the bitter melon group decreased (p = 0.014).

    View source

    Momordica charantia Administration Improves Insulin Secretion in Type 2 Diabetes Mellitus

    Score: 6/10
    2018
    rct
    n=24

    Cortez-Navarrete M, Martínez-Abundis E, Pérez-Rubio KG +2 more

    A significant increase in insulin AUC (56,562 ± 36,078 vs. 65,256 ± 42,720 pmol/L/min, P = .043)

    View source

    Momordica charantia for type 2 diabetes mellitus

    Score: 8/10
    2012
    meta_analysis
    n=479

    Ooi CP, Yassin Z, Hamid TA

    There is insufficient evidence to recommend Momordica charantia for type 2 diabetes; trials showed no statistically significant difference in glycaemic control versus placebo or metformin.

    View source

    Effects of Momordica charantia L. supplementation on glycemic control and lipid profile in type 2 diabetes mellitus patients: A systematic review and meta-analysis of randomized controlled trials

    Score: 7/10
    2024
    meta_analysis

    Nagarani G, et al.

    Pooled results suggested a small reduction in fasting blood glucose with M. charantia but no significant change in HbA1c or lipid profile, with GRADE certainty rated low.

    View source

    Safety

    Caveats

    The main risk here is substitution — delaying or displacing effective therapy in favour of a marginal one. Seeds contain vicine, a haemolysis risk in G6PD deficiency.

    Less likely to help if

    Most people with established type 2 diabetes. Those needing meaningful HbA1c reduction should not rely on this.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.